Changes in different parameters, lymphocyte proliferation and hematopoietic progenitor colony formation in EAE mice treated with myelin oligodendrocyte glycoprotein
暂无分享,去创建一个
S. Meuth | T. Budde | V. Buneva | G. Nevinsky | N. Popova | J. Lopatnikova | A. Korablev | L. Toporkova | I. Orlovskaya | T. A. Parkhomenko | Vasilii B. Doronin | Alina A. Alshevskaja | S. V. Sennikov | Alexey Korablev
[1] E. Granieri,et al. Comparison of Antibodies Hydrolyzing Myelin Basic Protein from the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis , 2014, PloS one.
[2] E. Granieri,et al. Comparison of DNA-Hydrolyzing Antibodies from the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis , 2014, PloS one.
[3] Bhanu P. Jena,et al. Journal of Cellular and Molecular Medicine , 2014, Journal of Cellular and Molecular Medicine.
[4] J. Goverman,et al. Modeling the heterogeneity of multiple sclerosis in animals. , 2013, Trends in immunology.
[5] G. Nevinsky. Natural Catalytic Antibodies in Norm and in HIV-Infected Patients , 2011 .
[6] F. Kasenga. Understanding HIV/AIDS Management and Care - Pandemic Approaches in the 21st Century , 2011 .
[7] V. Buneva,et al. Natural Catalytic Antibodies in Norm, Autoimmune, Viral, and Bacterial Diseases , 2010, TheScientificWorldJournal.
[8] V. Buneva,et al. Nucleotide-hydrolyzing antibodies from the sera of autoimmune-prone MRL-lpr/lpr mice. , 2009, International immunology.
[9] R. Beynon,et al. Limited variation in the major urinary proteins of laboratory mice , 2009, Physiology & Behavior.
[10] Daniel Thomas,et al. Recognition and Degradation of Myelin Basic Protein Peptides by Serum Autoantibodies: Novel Biomarker for Multiple Sclerosis1 , 2008, The Journal of Immunology.
[11] G. Nevinsky,et al. Formation of different abzymes in autoimmune-prone MRL-lpr/lpr mice is associated with changes in colony formation of haematopoietic progenitors , 2007, Journal of cellular and molecular medicine.
[12] V. Buneva,et al. Antibodies with amylase activity from the sera of autoimmune‐prone MRL/MpJ‐lpr mice , 2006, FEBS letters.
[13] O. Favorova,et al. Metal-dependent hydrolysis of myelin basic protein by IgGs from the sera of patients with multiple sclerosis. , 2006, Immunology letters.
[14] O. M. Durova,et al. Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[15] O. Favorova,et al. Hydrolysis of myelin basic protein by IgM and IgA antibodies from the sera of patients with multiple sclerosis. , 2005, Medical science monitor : international medical journal of experimental and clinical research.
[16] V. Buneva,et al. Natural Catalytic Antibodies – Abzymes , 2005 .
[17] A. Kulminskaya,et al. Catalytic properties of IgMs with amylolytic activity isolated from patients with multiple sclerosis. , 2004, Medical science monitor : international medical journal of experimental and clinical research.
[18] O. Favorova,et al. Hydrolysis of myelin basic protein by polyclonal catalytic IgGs from the sera of patients with multiple sclerosis , 2004, Journal of cellular and molecular medicine.
[19] A. Kulminskaya,et al. Human Abzymes with Amylolytic Activity , 2004 .
[20] V. Buneva,et al. Catalytic antibodies in healthy humans and patients with autoimmune and viral diseases , 2003, Journal of cellular and molecular medicine.
[21] S. Muller,et al. Anti-nucleosome antibodies and T-cell response in systemic lupus erythematosus. , 2002, Annales de medecine interne.
[22] Y. Nishi. Evolution of catalytic antibody repertoire in autoimmune mice. , 2002, Journal of immunological methods.
[23] V. Buneva,et al. Hematopoietic progenitor colony formation in the immunopathogenesis of the autoimmune disorder in MRL/MpJ-lpr mice. , 2002, Russian journal of immunology : RJI : official journal of Russian Society of Immunology.
[24] H. Hartung,et al. New concepts in the immunopathogenesis of multiple sclerosis , 2002, Nature Reviews Neuroscience.
[25] O. Favorova,et al. Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis. , 2001, Immunology letters.
[26] A. Bar-Or,et al. The Neuroimmunology of Multiple Sclerosis: Possible Roles of T and B Lymphocytes in Immunopathogenesis , 2001, Journal of Clinical Immunology.
[27] D. Burton,et al. Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] A. Cross,et al. B cells and antibodies in CNS demyelinating disease , 2001, Journal of Neuroimmunology.
[29] H. Hartung,et al. Patients with active relapsing‐remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: Implications for remyelination , 2000, Annals of neurology.
[30] H. Hartung,et al. The role of B cells and autoantibodies in multiple sclerosis , 2000, Annals of neurology.
[31] P. Schultz,et al. Opportunities at the interface of chemistry and biology. , 1999, Trends in cell biology.
[32] V. A. Naumov,et al. Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyze DNA and RNA. , 1998, Biochemistry. Biokhimiia.
[33] I. Astsaturov,et al. Novel functional activities of anti-dna autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases , 1998, Applied biochemistry and biotechnology.
[34] Dan S. Tawfik,et al. Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: is there a linkage to autoimmunity? , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[35] S. Avrameas,et al. IgG auto- and polyreactivities of normal human sera. , 1993, Molecular immunology.
[36] N. Copeland,et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.
[37] I Nicoletti,et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.
[38] Takato O. Yoshida,et al. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[39] Y. Shoenfeld,et al. Autoimmune diseases other than lupus share common anti-DNA idiotypes. , 1988, Immunology letters.
[40] D. Caputo,et al. Neuroimmunology in multiple sclerosis , 1983, The Italian Journal of Neurological Sciences.
[41] V. Buneva,et al. Autoantibodies and Natural Catalytic Antibodies in Health, Multiple Sclerosis, and Some Other Diseases , 2012 .
[42] Kim D. Janda,et al. Catalytic antibodies , 2007, Cell Biochemistry and Biophysics.
[43] H. Sinohara,et al. Does catalytic activity of bence-jones proteins contribute to the pathogenesis of multiple myeloma? , 2000, Applied biochemistry and biotechnology.
[44] S. Nagata,et al. Fas and Fas ligand: lpr and gld mutations. , 1995, Immunology today.
[45] A. Coutinho,et al. Natural autoantibodies. , 1995, Current opinion in immunology.
[46] S. Benkovic,et al. Recent developments in catalytic antibodies. , 1993, International reviews of immunology.
[47] Richard A. Lerner,et al. Antibodies as enzymes , 1987 .